Concepedia
Statistics
Publications
11
Citations
2K
H-Index
Active since
2021
Affiliations
University of Oxford(Current)
University of Bristol
Intensive Care National Audit & Research Centre
University College Dublin
Radboud University Nijmegen
Dominic Rimmer is an author at University of Oxford specializing in pharmacotherapy, pharmacy, and open-label trials.
Publications per year
2021–2023
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +6
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
Hesham Abdelhady, Marwa Abdelrazik, Zakee Abdi et al. · JAMA · 2021 · 212 citations · Full text
Medicine, Infectious Diseases, Internal Medicine +11
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 151 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +15
1–5 of 11